Processa Pharmaceuticals (PCSA) Invested Capital (2012 - 2025)
Processa Pharmaceuticals' (PCSA) quarterly Invested Capital came in at $3752.0 in Q2 2025, down 60.52% YoY from $9503.0 in Q2 2024, and down 25.94% on a QoQ basis from $5066.0 in Q1 2025.
Processa Pharmaceuticals (PCSA) Invested Capital (2012 - 2025) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 12 years of Invested Capital data on file, last reported at $3752.0 in Q2 2025.
- Quarterly Invested Capital fell 60.52% year-over-year to $3752.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $3752.0 (down 87.17% YoY) and the FY2024 annual result came in at $6602.0, changed N/A from the prior year.
- Invested Capital slipped to $3752.0 in Q2 2025, from $5066.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $41258.0 in Q1 2021 to a low of $1772.0 in Q4 2021.
- A 3-year average of $10963.4 and a median of $8067.0 in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2021 — Invested Capital tumbled 97.65% — and 2025, when it tumbled 53.56%.
- Tracing PCSA's Invested Capital over 3 years: stood at $1772.0 in 2021, then soared by 272.57% to $6602.0 in 2024, then tumbled by 43.17% to $3752.0 in 2025.
- The last three Invested Capital figures came in at $3752.0 (Q2 2025), $5066.0 (Q1 2025), and $6602.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3,752.00 |
| Mar 31, 2025 | 5,066.00 |
| Dec 31, 2024 | 6,602.00 |
| Sep 30, 2024 | 8,067.00 |
| Jun 30, 2024 | 9,503.00 |
| Mar 31, 2024 | 10,909.00 |
| Dec 31, 2021 | 1,772.00 |
| Jun 30, 2021 | 11,742.00 |
| Mar 31, 2021 | 41,258.00 |
| Dec 31, 2020 | 69,858.00 |
| Sep 30, 2020 | 762,229.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 803,573.00 |
| Dec 31, 2019 | 802,503.00 |
| Sep 30, 2019 | 25,727.00 |
| Jun 30, 2019 | 1,336.00 |
| Mar 31, 2019 | 230,000.00 |
| Dec 31, 2018 | 230,000.00 |
| Sep 30, 2018 | 100.00 |
| Jun 30, 2018 | 1,116.00 |